The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|10|6|579-594

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.10, Iss.6, 2009-07, pp. : 579-594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Inflammatory Actions of the Heme Oxygenase-1 Pathway

By  

Current Pharmaceutical Design, Vol. 9, Iss. 30, 2003-11 ,pp. : 2541-2551

Bentham Science Publishers

Access to resources Recommend Favorite

A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1370-1391

Bentham Science Publishers

Access to resources Recommend Favorite

Inducers of Heme Oxygenase-1

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 473-486

Bentham Science Publishers

Access to resources Recommend Favorite

Carbon monoxide modulates the response of human basophils to Fc &unknown; RI stimulation through the heme oxygenase pathway

By Vannacci A.   Baronti R.   Zagli G.   Marzocca C.   Pierpaoli S.   Bani D.   Passani M.B.   Mannaioni P.F.   Masini E.  

European Journal of Pharmacology, Vol. 465, Iss. 3, 2003-04 ,pp. : 289-297

Elsevier

Access to resources Recommend Favorite

New Biotechnological Methods to Reduce Oxidative Stress in the Cardiovascular System: Focusing on the Bach1/Heme Oxygenase-1 Pathway

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 2, 2006-04 ,pp. : 87-93

Bentham Science Publishers

Access to resources Recommend Favorite